We are live on ! Find out more
PFA

Pathway Financial Advisers Portfolio holdings

AUM $397M
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.93%
3 Year Est. Return
+82.41%
5 Year Est. Return
10 Year Est. Return
AUM
$278M
AUM Growth
+$15.1M
Cap. Flow
-$1.85M
Cap. Flow %
-0.67%
Top 10 Hldgs %
21.19%
Holding
504
New
38
Increased
151
Reduced
174
Closed
56

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.39M
2
ALL icon
Allstate
ALL
+$1.29M
3
AVGO icon
Broadcom
AVGO
+$1.16M
4
BX icon
Blackstone
BX
+$575K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$503K

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Financials 11.45%
3 Healthcare 10.53%
4 Industrials 9.19%
5 Energy 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$383B
$3.21M 1.16%
6,488
-200
-3% -$102K
WM icon
27
Waste Management
WM
$90.5B
$3.07M 1.11%
14,407
-1,447
-9% -$284K
VIG icon
28
Vanguard Dividend Appreciation ETF
VIG
$112B
$3.06M 1.1%
16,748
+1,853
+12% +$326K
WMT icon
29
Walmart Inc
WMT
$884B
$3.05M 1.1%
50,671
-3,788
-7% -$217K
MCD icon
30
McDonald's
MCD
$191B
$2.99M 1.08%
10,604
-325
-3% -$94.5K
MRK icon
31
Merck
MRK
$321B
$2.89M 1.04%
21,935
+2,249
+11% +$277K
OHI icon
32
Omega Healthcare
OHI
$15.1B
$2.83M 1.02%
89,216
+2,312
+3% +$70.3K
PDT
33
John Hancock Premium Dividend Fund
PDT
$636M
$2.56M 0.92%
219,807
+2,505
+1% +$28K
RTX icon
34
RTX Corp
RTX
$289B
$2.46M 0.88%
25,205
+2,068
+9% +$187K
CVS icon
35
CVS Health
CVS
$134B
$2.42M 0.87%
30,357
+183
+0.6% +$14K
CMI icon
36
Cummins
CMI
$87.3B
$2.41M 0.87%
8,185
-73
-0.9% -$18.8K
VICI icon
37
VICI Properties
VICI
$29B
$2.4M 0.86%
80,475
+2,887
+4% +$86.7K
UPS icon
38
United Parcel Service
UPS
$89.5B
$2.39M 0.86%
16,085
+234
+1% +$35.6K
PM icon
39
Philip Morris
PM
$299B
$2.3M 0.83%
25,139
+1,350
+6% +$124K
QCOM icon
40
Qualcomm
QCOM
$159B
$2.29M 0.82%
13,521
-824
-6% -$127K
APD icon
41
Air Products & Chemicals
APD
$66.8B
$2.25M 0.81%
9,277
+637
+7% +$156K
WLKP icon
42
Westlake Chemical Partners
WLKP
$766M
$2.17M 0.78%
97,692
+1,532
+2% +$34.4K
KO icon
43
Coca-Cola
KO
$381B
$2.11M 0.76%
34,459
-903
-3% -$54.2K
EMR icon
44
Emerson Electric
EMR
$83.3B
$2.09M 0.75%
18,470
+129
+0.7% +$13.3K
FDVV icon
45
Fidelity High Dividend ETF
FDVV
$10.2B
$2.04M 0.74%
45,132
+3,624
+9% +$158K
BIP icon
46
Brookfield Infrastructure Partners
BIP
$19.5B
$2.04M 0.73%
65,232
+2,180
+3% +$66.1K
HD icon
47
Home Depot
HD
$332B
$2.02M 0.73%
5,263
-456
-8% -$167K
MET icon
48
MetLife
MET
$62.5B
$2.01M 0.72%
27,172
-761
-3% -$53K
PSX icon
49
Phillips 66
PSX
$84.4B
$1.95M 0.7%
11,909
-202
-2% -$29.1K
WPC icon
50
W.P. Carey
WPC
$16.9B
$1.9M 0.68%
33,600
+1,588
+5% +$95K

Similar funds

Pathway Financial Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Pathway Financial Advisers held 504 positions worth $278M, up 5.8% from $263M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Pathway Financial Advisers's Q1 2024 filing shows 38 new, 151 increased, 174 reduced and 56 closed positions. Its largest new stake was DoubleLine Yield Opportunities Fund: 35,973 shares worth $573K. The largest sale was Bristol-Myers Squibb, an estimated $1.39M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Pathway Financial Advisers's largest Q1 2024 buy was DoubleLine Yield Opportunities Fund: 35,973 shares worth $573K.
  • Pathway Financial Advisers added most to XPLR Infrastructure LP in Q1 2024, an estimated $1.01M increase.
  • Pathway Financial Advisers's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.39M.
  • Pathway Financial Advisers fully exited Sysco in Q1 2024, selling an estimated $200K.
  • Pathway Financial Advisers's ten largest holdings make up 21% of its $278M portfolio in Q1 2024.
  • Pathway Financial Advisers opened 38 new positions and closed 56 in Q1 2024.
  • Pathway Financial Advisers's portfolio value rose 5.8% quarter-over-quarter to $278M.

Based on Pathway Financial Advisers's 13F filing for Q1 2024, filed 29 May 2024.